Laennec Inj

LAENNEC INJ

LAENNEC INJ brings a clearly defined professional profile to professional treatment planning, using water-soluble human placental hydrolysate for regulated professional pharmaceutical use. The result is a product with a defined place in the range rather than a one-size-fits-all option.

What Stands Out

A closer look at LAENNEC INJ shows a product built around practical choices: what it contains, the type of correction it supports and how it differs from adjacent variants.

• Formulation focus: water-soluble human placental hydrolysate
• Main professional objectives: regulated professional pharmaceutical use
• Presentation details: 112 mg per 2 ml ampoule

1. Exact Product Identity

The manufacturer lists each 2 ml ampoule as containing 112 mg of water-soluble human placental hydrolysate. A pH-adjusting agent is included as an inactive ingredient. This exact composition is the strongest basis for presenting Laennec accurately and differentiating it from cosmetic placenta serums or unrelated injectable boosters.

2. Manufacturing and Source Context

Japan Bio Products describes Laennec as a human-placenta-derived pharmaceutical manufactured using its proprietary extraction technologies. Because it is an ethical drug, product handling, supply and administration must follow the authorised professional channel and the locally approved product information.

3. What the Product Page Should Communicate

• Exact 2 ml ampoule presentation
• 112 mg water-soluble human placental hydrolysate per ampoule
• Pharmaceutical rather than cosmetic product status
• Professional procurement, storage and administration requirements
• Verification of the current regional label before use

4. Practical Procurement Checks

Clinics and distributors should verify the manufacturer, regional packaging, intact ampoules, lot and expiry information, and the applicable authorised supply route. Japan Bio Products specifically states that it does not sell Laennec Injection over the internet, making supply-chain verification particularly important.

5. Professional Use

Laennec should not be described as an under-eye filler, a facial contouring product or a general-purpose cosmetic injection. Indication, patient selection, dosage, administration route and monitoring must come from the locally approved prescribing information and the responsible healthcare professional.

Product Summary

• Product: Laennec Injection
• Manufacturer: Japan Bio Products Co., Ltd.
• Active material: Water-soluble human placental hydrolysate
• Declared content: 112 mg per 2 ml ampoule
• Classification: Ethical prescription medicine
• Intended channel: Regulated professional supply

Frequently Asked Questions

What is the main ingredient in Laennec?

The manufacturer identifies the active material as water-soluble human placental hydrolysate, with 112 mg contained in each 2 ml ampoule.

Is Laennec a dermal filler?

No. It is a placenta-derived pharmaceutical and should not be presented as a hyaluronic-acid filler or structural volumising gel.

Can the website provide an injection protocol?

Administration information must follow the locally approved prescribing information and qualified professional judgement.